Blue Apron reported a smaller drop in revenue than expected for the fourth quarter on Tuesday. Tonya Garcia, Retail Reporter at MarketWatch and Jason Moser, Analyst at The Motley Fool, join The Long and The Short to discuss where the meal kit delivery company goes from here.
The main focus on Blue Apron has been its customer growth. This quarter it reported a loss of 15% year-over-year in customers, reflecting a cut in marketing spend. Moser says the company's biggest issue is building up that loyal customer base with the little amount of money it has for marketing. It won't make investors feel at ease until they see some solid growth in the user category.
Plus, what sets Blue Apron apart from the others? Garcia says in this type of competitive industry each company needs to have that one thing others don't. Right now, she's not seeing anything unique about Blue Apron. She's hoping if it ramps up market spending it can figure out that key piece to the puzzle.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
